Nvax stock price recorded a 0

NVAX stock price recorded a 0.9% gain to $4.64 despite broader healthcare sector weakness. Technical setups suggest NVAX is consolidating ahead of a possible breakout, contingent on biotech market sentiment turning bullish. NVAX | Novavax Inc. Stock Overview (U.S.: Nasdaq) | Barron's For the next fiscal year, the consensus earnings estimate of $0.23 indicates a change of -91.3% from what Novavax is expected to report a year ago. Over the past month, the estimate has changed -50.4%. NVAX stock price traded flat at $4.65 as market participants awaited U.S. and EU regulatory announcements. Historically, such events have led to rapid price swings, creating opportunities for both swing traders and long-term investors.